Does magnesium augment the pain relieving effects of low dose intravenous lidocaine (lignocaine) in patients with chronic non malignant pain? A randomised double-blind crossover study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN12273453

Enrollment

Registered

2004-09-30

Start date

2004-04-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Signs and Symptoms: Pain Signs and Symptoms Pain

Interventions

1. Lignocaine 2. Non lignocaine

Eligibility

Inclusion criteria

Inclusion criteria: 20 patients from Pain Management

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
Change in pain score following treatment.	—

Secondary

Measure	Time frame
Number of patients receiving >50% pain relief, pain relief intensity and sleep interference, duration of pain relief, number and frequency of adverse events, effect on blood pressure.	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026